Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01954095 · ClinicalTrials.gov registry record

The Impact of Vaginal and IM Progestins on the Cervix

A clinical trial of Preterm Birth and Short Cervical Length, sponsored by University of Pittsburgh.

Completed
Registry status
89
Enrollment target
4
Study locations

NCT01954095 is a study of Preterm Birth and Short Cervical Length that has completed, run by University of Pittsburgh. The registered enrollment target is 89 participants, below the 4,627-participant average among 37 other Preterm Birth trials with a reported enrollment target (98% lower). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01954095, a study of Preterm Birth and Short Cervical Length, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
89 participants
Enrollment target
4
Study locations

Study Summary

The purpose of this study is to analyze how the body handles and responds to progesterone treatment in parous and nulliparous women at risk of pre-term birth.

Conditions Studied

Preterm Birth Short Cervical Length

Study Locations (4)

Indiana

  • Indiana University School of Medicine - Indianapolis

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Texas

  • University of Texas Medical Branch - Galveston

Washington

  • University of Washington - Seattle

Trial Details

FieldValue
Enrollment Target 89 participants
Start Date 2013-08
Est. Completion 2015-03

Sponsor

University of Pittsburgh

1,238 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01954095

The ClinicalTrials.gov registry entry for NCT01954095 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 89 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,627-participant average among 37 other Preterm Birth trials with a reported enrollment target (98% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Preterm Birth appearing as the primary indexed condition, and to 0 interventions.

NCT01954095 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Indiana, Pennsylvania, Texas.

Frequently Asked Questions

What is clinical trial NCT01954095 about?

NCT01954095 is a clinical study titled "The Impact of Vaginal and IM Progestins on the Cervix". The purpose of this study is to analyze how the body handles and responds to progesterone treatment in parous and nulliparous women at risk of pre-term birth.

What is the current status of trial NCT01954095?

This trial is currently completed. The enrollment target is 89 participants. The study started on 2013-08. Estimated completion is 2015-03.

What conditions does trial NCT01954095 study?

This clinical trial studies the following conditions: Preterm Birth, Short Cervical Length.

Who is sponsoring clinical trial NCT01954095?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01954095 being conducted?

This trial has 4 study locations across Indiana, Pennsylvania, Texas, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Preterm Birth

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Preterm Birth

All registered trials for this condition

Short Cervical Length

All registered trials for this condition

Indiana

All trials with a study site in Indiana

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.